Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647019 | SCV000768805 | benign | Herpes simplex encephalitis, susceptibility to, 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001702539 | SCV005306582 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702539 | SCV001929538 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702539 | SCV001967214 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003980254 | SCV004789140 | benign | TLR3-related disorder | 2019-05-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |